Greenland Mines Ltd SEC filings GRML
Greenland Mines Ltd has 268 filings in SEC EDGAR's recent list, going back to Jan 31, 2022. Its latest annual report, Form 10-K, was filed on Apr 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 17, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 2, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Jun 22, 2026 | Jul 16, 2026 |
| PRE 14A | Preliminary proxy statement | Jun 9, 2026 | Jun 9, 2026 |
| DEF 14A | Proxy statement | May 26, 2026 | Jun 18, 2026 |
| PRE 14A | Preliminary proxy statement | May 15, 2026 | May 15, 2026 |
| DEF 14A | Proxy statement | Jan 23, 2026 | Feb 13, 2026 |
| PRE 14A | Preliminary proxy statement | Jan 12, 2026 | Jan 12, 2026 |
| PRE 14A | Preliminary proxy statement | May 28, 2025 | May 27, 2025 |
| DEF 14A | Proxy statement | May 5, 2025 | May 28, 2025 |
| PRE 14A | Preliminary proxy statement | Mar 27, 2025 | Mar 26, 2025 |
| DEFM14A | Proxy statement | Feb 20, 2024 | — |
| DEFA14A | Additional proxy material | Nov 7, 2023 | — |
| DEFA14A | Additional proxy material | Nov 6, 2023 | — |
| DEF 14A | Proxy statement | Nov 2, 2023 | Nov 13, 2023 |
| PRE 14A | Preliminary proxy statement | Oct 16, 2023 | Oct 16, 2023 |
| DEFA14A | Additional proxy material | Mar 27, 2023 | — |
| DEF 14A | Proxy statement | Mar 20, 2023 | Mar 31, 2023 |
| PRE 14A | Preliminary proxy statement | Feb 24, 2023 | Feb 24, 2023 |
Showing 17 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- GRML (Nasdaq), GRMLW (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Omaha, NE
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1907223
- Former names
- Klotho Neurosciences, Inc. (until Mar 10, 2026); ANEW Medical, Inc. (until Sep 18, 2024); Redwoods Acquisition Corp. (until Jun 21, 2024)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.